Antifungal Prophylaxis in Critically Ill Patients
Author Information
Author(s): van Till JW Olivier, van Ruler Oddeke, Lamme Bas, Weber Roy JP, Reitsma Johannes B, Boermeester Marja A
Primary Institution: Academic Medical Center, Amsterdam, The Netherlands
Hypothesis
The study aims to determine and compare the effectiveness of different prophylactic antifungal therapies in critically ill patients.
Conclusion
Both single-drug antifungal prophylaxis and selective decontamination of the digestive tract are effective in reducing yeast colonisation and infections in critically ill patients, with SDD showing greater effectiveness.
Supporting Evidence
- Both SAP and SDD reduced the incidence of yeast colonisation.
- SDD was more effective than SAP in reducing yeast-related outcomes.
- Mortality was reduced predominantly by SDD.
Takeaway
Doctors can give special medicines to sick patients to help stop yeast infections, and one method works better than the other.
Methodology
A systematic review of prospective trials comparing single-drug antifungal prophylaxis and selective decontamination of the digestive tract with controls.
Potential Biases
Potential publication bias and selective reporting of outcomes.
Limitations
Most studies had small sample sizes and varied definitions for yeast colonisation and infection.
Participant Demographics
Median age was 55 years, with 38% females and 49% surgical patients.
Statistical Information
Confidence Interval
95% CI 0.20 to 0.70 for SAP; 95% CI 0.05 to 0.29 for SDD
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website